|
|
The clinical curative effect of Vinpocetine combined with Shuxuetong Injection in treatment of acute cerebral infarction |
ZHANG Xiao-xia |
Department of Neurology,Pulandian Central Hospital,Liaoning Province,Dalian 116200,China |
|
|
Abstract Objective To investigate the clinical effect of Vinpocetine combined with Shuxuetong Injection in treatment of acute cerebral infarction.Methods 86 cases of patients with acute cerebral infarction admitted in our hospital from January 2015 to January 2016 were selected as the study subjects.They were divided into study group and control group according to different treatment methods,each group of 43 cases.The patients in two groups were treated with oxygen inhalation,maintenance of vital signs,Aspirin oral,intravenous input of brain cell nutrition,blood lipid-lowering drug and other symptomatic and supportive treatment.The patients in the study group were given Vinpocetine 20 mg joined in 0.9% Sodium Chloride Injection 250 ml intravenous drip,1 time a day,Shuxuetong Injection 6 ml joined in 5% Glucose Injection 250 ml intravenous drip,1 time a day,the course of treatment was 14 days.The patients in the control group were treated with Citicoline 0.75 g joined in 0.9% Sodium Chloride Injection 250 ml intravenous drip,Fufang Danshen injection 20 ml joined in 5% Glucose Injection 250 ml intravenous drip,1 time a day,the course of treatment was 14 days.The clinical efficacy of the two groups were compared,the changes of NIHSS and ADL scores before and after treatment in the two groups were also compared.Results After treatment,the total effective rate of patients in the study group (97.6%) was higher than that in the control group (76.7%),and the difference was statistically significant (P<0.05).NIHSS and ADL scores were compared in the two groups before treatment,and the differences were not statistically significant (P>0.05).After treatment,the ADL score of the patients in the study group was significantly higher than that in the control group,the NIHSS score was significantly lower than that in the control group,and the differences were statistically significant (P<0.05).Conclusion Vinpocetine combined with Shuxuetong Injection in the treatment of acute cerebral infarction can significantly improve the neurological function and the life quality of patients.It is worthy of clinical popularization and application.
|
Received: 03 July 2017
|
|
|
|
|
[7] |
张志亮,侯梦霞,曹冬梅,等.疏血通联合奥扎格、雷钠治疗急性脑梗死疗效观察[J].山东医药,2011,51(33):101-102.
|
[1] |
徐昕宇.疏血通注射液治疗急性脑梗塞随机平行对照研究[J].实用中医内科杂志,2013,27(1):35-36.
|
[2] |
李洪云,韩冬梅.疏血通注射液治疗急性脑梗塞临床疗效观察[J].北方药学,2015,12(4):68-69.
|
[3] |
殷运收.疏血通注射液的药理作用及临床应用新进展[J].临床医学工程,2011,18(3):472-473.
|
[4] |
杨媛芬,李淑华.疏血通联合依达拉奉治疗脑梗死的疗效分析[J].中国当代医药,2013,20(9):107-108
|
[5] |
黎彬如,龙佳佳,韦宁.疏血通联合依达拉奉治疗老年脑梗死患者的疗效[J].中国老年学杂志,2015,35(10):2691-2692.
|
[6] |
纪丰海.疏血通联合奥扎格雷治疗急性脑梗死 40例疗效观察[J].齐齐哈尔医学院学报,2010,31(23):3772-3773.
|
[8] |
刘立.疏血通治疗急性脑梗死70例疗效分析[J].当代医学,2014,20(17):122-123.
|
[9] |
王丽靖,叶淑萍,周宏,等.疏血通注射液与丁苯酞注射液联合治疗急性脑梗死的临床效果研究[J].中国医药科学,2016,6(20):43-45.
|
[10] |
张玲.疏血通、奥扎格雷、依达拉奉三联疗法治疗急性脑梗死的疗效分析[J].当代医学,2014,20(3):155-156.
|
[11] |
姚东陂,张锦丽,李玲,等.长春西汀注射液治疗急性脑梗死效果观察[J].解放军医药杂志,2013,25(2):46-47.
|
[12] |
杨学东.长春西汀治疗急性脑梗死患者的疗效观察[J].中国药物经济学,2016,11(6):82-83.
|
[13] |
陈志刚,刘长,易欣.长春西汀在急性脑梗死患者的应用价值[J].中国实用神经疾病杂志,2016,19(10):84-85.
|
[14] |
谢多英,晏廷念.长春西汀对急性脑梗死患者血液学指标及血管内皮分泌功能的影响[J].四川医学,2011,32(6):925-926.
|
[15] |
王福春,汤新强.长春西汀的临床应用进展[J].大连医科大学学报,2009,31(3):364-369.
|
[16] |
易玉新,张萍,王蓉,等.长春西汀对老年急性脑梗死的临床治疗作用[J].中国现代药物应用,2013,7(12):18-19.
|
[17] |
张广山.长春西汀联合血栓通治疗脑梗死42例疗效观察[J].中国现代药物应用,2013,7(18):149-150.
|
[18] |
周金龙.长春西汀联合疏血通治疗急性脑梗死的疗效观察[J].中西医结合心脑血管病杂志,2012,10(8):945-946.
|
[19] |
张俊英.长春西汀联合疏血通治疗急性脑梗死的临床效果观察[J].中国现代医生,2015,53(34):34-35.
|
[20] |
朱春丽,彭一鹏,欧阳存,等.远端缺血后适应处理对急性脑梗死患者血清促炎因子和抗炎因子的影响及其临床意义[J].疑难病杂志,2016,15(3):241-244.
|
|
|
|